These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38375772)

  • 21. Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives.
    Tran TTV; Surya Wibowo A; Tayara H; Chong KT
    J Chem Inf Model; 2023 May; 63(9):2628-2643. PubMed ID: 37125780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
    Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial Intelligence in Drug Formulation and Development: Applications and Future Prospects.
    Noorain ; Srivastava V; Parveen B; Parveen R
    Curr Drug Metab; 2023; 24(9):622-634. PubMed ID: 37779408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
    Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
    Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generative artificial intelligence empowers digital twins in drug discovery and clinical trials.
    Bordukova M; Makarov N; Rodriguez-Esteban R; Schmich F; Menden MP
    Expert Opin Drug Discov; 2024; 19(1):33-42. PubMed ID: 37887266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.
    Singh S; Kumar R; Payra S; Singh SK
    Cureus; 2023 Aug; 15(8):e44359. PubMed ID: 37779744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine learning approaches and their applications in drug discovery and design.
    Priya S; Tripathi G; Singh DB; Jain P; Kumar A
    Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
    Huang DZ; Baber JC; Bahmanyar SS
    Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial Intelligence in Drug Design.
    Hessler G; Baringhaus KH
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30279331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial Intelligence and Cancer Drug Development.
    Yang F; Darsey JA; Ghosh A; Li HY; Yang MQ; Wang S
    Recent Pat Anticancer Drug Discov; 2022; 17(1):2-8. PubMed ID: 34323201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AI-based language models powering drug discovery and development.
    Liu Z; Roberts RA; Lal-Nag M; Chen X; Huang R; Tong W
    Drug Discov Today; 2021 Nov; 26(11):2593-2607. PubMed ID: 34216835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of artificial intelligence in drug delivery system design.
    Hassanzadeh P; Atyabi F; Dinarvand R
    Adv Drug Deliv Rev; 2019; 151-152():169-190. PubMed ID: 31071378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical assessment of AI in drug discovery.
    Walters WP; Barzilay R
    Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
    [No Abstract]   [Full Text] [Related]  

  • 37. CADD, AI and ML in drug discovery: A comprehensive review.
    Vemula D; Jayasurya P; Sushmitha V; Kumar YN; Bhandari V
    Eur J Pharm Sci; 2023 Feb; 181():106324. PubMed ID: 36347444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advancing health care via artificial intelligence: From concept to clinic.
    Sandeep Ganesh G; Kolusu AS; Prasad K; Samudrala PK; Nemmani KVS
    Eur J Pharmacol; 2022 Nov; 934():175320. PubMed ID: 36220360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Artificial Intelligence in Drug Discovery.
    Chopra H; Baig AA; Gautam RK; Kamal MA
    Curr Pharm Des; 2022; 28(33):2690-2703. PubMed ID: 35676841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.